
|Articles|February 1, 2002
LHRH investigation still active, despite settlement
San Francisco-Despite a settlement by TAP Pharmaceuticals last fall on charges concerning fraudulent pricing and marketing of leuprolide acetate (Lupron)
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
2
Praful Ravi, MB, BChir, MRCP, on PSMA-PET during initial systemic therapy for mHSPC
3
Study suggests potential diuretic effect with nadofaragene firadenovec
4
Clint Bahler, MD, reflects on precision medicine and focal therapy highlights at AUA 2026
5











